Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Cilnidipine: a new generation Ca channel blocker with inhibitory action on sympathetic neurotransmitter release Takahara ACardiovasc Ther 2009[Sum]; 27 (2): 124-39Cilnidipine is a unique Ca(2+) channel blocker with an inhibitory action on the sympathetic N-type Ca(2+) channels, which is used for patients with hypertension in Japan. Cilnidipine has been clarified to exert antisympathetic actions in various examinations from cell to human levels, in contrast to classical Ca(2+) channel blockers. Furthermore, renoprotective and neuroprotective effects as well as cardioprotective action of cilnidipine have been demonstrated in clinical practice or animal examinations. After the introduction of nifedipine as an antihypertensive drug, many Ca(2+) channel blockers with long-lasting action for blood pressure have been developed to minimize sympathetic reflex during antihypertensive therapy, which have been divided into three groups; namely, first, second, and third generation based on their pharmacokinetic profiles. Since cilnidipine directly inhibits the sympathetic neurotransmitter release by N-type Ca(2+) channel-blocking property, the drug can be expected as fourth generation, providing an effective strategy for the treatment of cardiovascular diseases.|Adrenergic Fibers/*drug effects/metabolism[MESH]|Animals[MESH]|Antihypertensive Agents/history/*therapeutic use[MESH]|Blood Pressure/drug effects[MESH]|Calcium Channel Blockers/adverse effects/history/*therapeutic use[MESH]|Calcium Channels, N-Type/*drug effects/metabolism[MESH]|Dihydropyridines/adverse effects/history/*therapeutic use[MESH]|History, 20th Century[MESH]|History, 21st Century[MESH]|Humans[MESH]|Hypertension/*drug therapy/metabolism/physiopathology[MESH]|Norepinephrine/*metabolism[MESH]|Reflex/drug effects[MESH]|Treatment Outcome[MESH] |
